← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 30, 2016Last known activity
Apr 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 6 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT05795660Lead sponsorPhase 1Apr 1, 2023
- NCT05795660Reponsible party - principal investigatorPhase 1Apr 1, 2023
- NCT04576975CollaboratorPhase 3Dec 30, 2020
- NCT04576975Study directorPhase 3Dec 30, 2020
- NCT04604223CollaboratorPhase 4Nov 15, 2020
- NCT04451239CollaboratorN/AJun 30, 2020
- NCT04474340Lead sponsorPhase 1May 21, 2020
- NCT04474340Reponsible party - principal investigatorPhase 1May 21, 2020
- NCT04617613CollaboratorPhase 4Sep 30, 2016
Details
- Last known activity
- Apr 1, 2023